Allergic contact dermatitis from cross-reacting beta-blocking agents.
Corazza
M
M
Clinica Dermatologica, Università di Ferrara, Italy.
Virgili
A
A
Mantovani
L
L
Masieri
L T
LT
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D017449:Dermatitis, Allergic Contact / Q000276:immunology*; D003875:Drug Eruptions / Q000276:immunology*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008875:Middle Aged; D009883:Ophthalmic Solutions; D011412:Propanolamines / Q000009:adverse effects* / Q000627:therapeutic use; D013999:Timolol / Q000009:adverse effects* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D011412:Propanolamines; C006034:befunolol; D013999:Timolol